| 摘要 |
A method for prognosing of risk of recurrent coronary events development after acute coronary syndrome, where during hospitalization the estimation of patient state with pains behind the chest or symptoms, characteristic for myocardial ischemia, is performed by means of conventional studies with the analysis of objective statuse and availability or absence of chamges in ECG, clinical form of acute coronary syndrome is determined, with ST segment raising or without it, and in patients with the acute coronary syndrome without ST segment raising the biochemical studies of blood serum are performed with determination and estimation as myocardial necrosis – troponin (Th I) concentration, as prognostic criterion of inflammatory process state in the myocardium - C-reactive protein (CRP) concentration, as a marker of left ventricle dysfunction and cardiac insufficiency (CI) – concentration of NT-fraction of cerebral natriumurethic peptide (NT-CNP). Additionally and simultaneously in blood serum interleucin-10 (IL-10) concentration id determined as estimated as a marker of immune anti-inflammatory blood activity.The prognostic criteria are determined and estimated together in the acute period (during hospitalization) and on the 7 day from the disease beginning. |
